Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19. - Unoh Y; Hirai K; Uehara S; Kawashima S; Nobori H; Sato J; Shibayama H; Hori A; Nakahara K; Kurahashi K; Takamatsu M; Yamamoto S; et al. (Journal of medicinal chemistry, 2025)